Thursday, 06 August 2020

Korea's Dongsung Pharmaceuticals opens a new cancer research center in Seoul

14 November 2017 | News

Thecancer center can help Dongsung Pharma move a step forward to advancing its cancer treatment development

In a bid to further strengthen its pipeline of cancer treatments, Korea’s Dongsung Pharmaceuticals has recently opened a new cancer research and development center in Daegu, southeast of capital city Seoul.

The new cancer R&D center is established in a state-designed Daegu medical complex where 15 public institutions and 120 other private medical firms are settled. 

Dongsung said in a statement that that the new cancer center can help it move a step forward to advancing its cancer treatment development. The pharmaceutical firm that is currently in partnership with local drug research and development support centers has been developing new anti-cancer agents and studying photodynamic therapy for cancer treatment since June last year. 

Lee Yang-gu, chief executive officer of Dongsung Pharmaceutical, said, “The company aims to complete the development of a new photosensitizing agent, a drug used in photodynamic therapy for cancer treatment, at the Daegu cancer center by the end of this year.”

Korea based Dongsung Pharmaceutical, mainly produces over-the-counter drugs and quasi-drugs, and has been seeking to expand its reach out to the global medical market through cancer treatment drugs. 

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account



Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls